Abstract
Neuroinflammation can lead to chronic maladaptive pain affecting millions of people worldwide. Neurotransmitters, cytokines, and ion channels are implicated in neuroimmune cell signaling, but their roles in specific behavioral responses are not fully elucidated. Voltage-gated CaV2.2 channel activity in skin controls rapid and transient heat hypersensitivity induced by intradermal (i.d.) capsaicin via IL-1ɑ cytokine signaling. CaV2.2 channels are not, however, involved in mechanical hypersensitivity that developed in the i.d. capsaicin animal model. Here, we show that CaV2.2 channels are also critical for heat hypersensitivity induced by i.d. complete Freund adjuvant (CFA). i.d. CFA, a model of chronic neuroinflammation, involves ongoing cytokine signaling for days leading to pronounced edema and hypersensitivity to sensory stimuli. Peripheral CaV2.2 channel activity in the skin was required for the full development and week-long time course of heat hypersensitivity induced by i.d. CFA, but paw edema and mechanical hypersensitivity were independent of CaV2.2 channel activity. CFA induced increases in several cytokines in hindpaw fluid including IL-6 which was also dependent on CaV2.2 channel activity. Using IL-6–specific neutralizing antibodies in vivo, we show that IL-6 contributes to heat hypersensitivity and that neutralizing both IL-1ɑ and IL-6 was even more effective at reducing the magnitude and duration of CFA-induced heat hypersensitivity. Our findings demonstrate a functional link between CaV2.2 channel activity and the release of IL-6 in the skin and show that CaV2.2 channels have a privileged role in the induction and maintenance of heat hypersensitivity during chronic forms of neuroinflammation in the skin.
- chronic pain
- hypersensitivity
- inflammatory cytokines
- neuroinflammation
- nociception
- peripheral sensitization
- voltage-gated calcium channels
Footnotes
The authors declare no competing financial interests.
Inflammatory cytokines in hindpaw fluid samples were validated using the Fluid Biomarkers Laboratory at the Carney Institute for Brain Science at Brown University’s Center for Alzheimer's Disease Research. We thank Kristine Pelton, Manager of the Fluid Biomarkers Laboratory facility, for her technical assistance. This work was supported by NINDS NS055251 (D.L.); NHLBI R01HL165259 (A.M.J.), NHLBI R01HL126887 (A.M.J.), NIGMS P20GM121344 and R25GM083270 Pilot Project (A.M.J.), and Carney Institute for Brain Science Innovation Award (A.M.J.).
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.






